![]() Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | ![]() ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. | Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. | |
Founding Date | Founding Date 2013 | Founding Date 1993 | Founding Date 1878 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Francisco, US HQ | Locations San Diego, US HQ Princeton, US | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more |
Employees | Employees 2382% decrease | Employees 513 | Employees 4,955 |
Valuation ($) | Valuation ($) 495.3 m | Valuation ($) 2.4 b | Valuation ($) 12.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) ¥499.7b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $89m (FY, 2025) | Cost of goods ¥55.5b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $982.5m (FY, 2025) | Gross profit ¥491.3b (FY, 2026) |
Net income | Net income ($142.9m) (FY, 2025) | Net income $391m (FY, 2025) | Net income ¥205.9b (FY, 2026) |
Funding | |||
Total funding raised | Total funding raised $ 194.5m | Total funding raised $ 770.8m | Total funding raised $ 4.7m |

ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companyShionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View company